GLP-1 weight loss uses medications that act on glucagon-like peptide-1 pathways involved in appetite, satiety, digestion, and blood sugar regulation
Last reviewed: May 26, 2026 Last updated: May 26, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
It acts as a selective ghrelin receptor agonist
The Mechanisms of Semaglutide Therapy in Heart Failure Patients trial will assess the impact of semaglutide on biomarkers, echocardiographic parameters, and functional outcomes in patients with HF [63]
Stack with NAD+ or exercise
METHOD ARCHITECTURE Labrada Nutrition, headquartered in Houston, TX was founded in 1995 by IFBB Pro Bodybuilding Hall of Famer and former Mr